PharmaTher Holdings Ltd., a company focused on the development and commercialization of specialty ketamine prescription-based products, is pleased to provide a product pipeline update and expected milestones for 2022.
Compound Ketamine
Visit article
Category Press Release
Companies Featured
PharmaTherPharmather is a Canadian life sciences listed company that is developing psychedelics for brain and nervous system disorders.